- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2011-005178-43. Displaying page 1 of 1.
|EudraCT Number: 2011-005178-43||Sponsor Protocol Number: OMB115991||Start Date*: 2012-02-08|
|Sponsor Name:GlaxoSmithKline Research & Development Limited|
|Full Title: A Phase II, Multi-centre Study Investigating the Safety and Efficacy of Ofatumumab and Bendamustine Combination in Patients with Untreated or Relapsed Chronic Lymphocytic Leukaemia (CLL)|
|Medical condition: Untreated or Relapsed Chronic Lymphocytic Leukaemia|
|Population Age: Adults, Elderly||Gender: Male, Female|
|Trial protocol: CZ (Completed) DE (Prematurely Ended) BE (Completed) ES (Ongoing) PL (Completed) GR (Completed) IT (Completed)|
|Trial results: View results|
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
|Number of Trials to download:|
• Outside EU/EEA: Date study was submitted in EudraCT
Query did not match any studies.